169 related articles for article (PubMed ID: 23827598)
1. Study of drug-eluting coating on metal coronary stent.
Shanshan C; Lili T; Yingxue T; Bingchun Z; Ke Y
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1476-80. PubMed ID: 23827598
[TBL] [Abstract][Full Text] [Related]
2. Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray.
Kim SJ; Park JG; Kim JH; Heo JS; Choi JW; Jang YS; Yoon J; Lee SJ; Kwon IK
J Nanosci Nanotechnol; 2011 Jul; 11(7):5689-97. PubMed ID: 22121592
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and in vitro anticoagulation of emodin-eluting controlled biodegradable stent coatings.
Pan CJ; Wang J; Huang N
Colloids Surf B Biointerfaces; 2010 Jun; 77(2):155-60. PubMed ID: 20194006
[TBL] [Abstract][Full Text] [Related]
4. Effect of solvent on drug release and a spray-coated matrix of a sirolimus-eluting stent coated with poly(lactic-co-glycolic acid).
Choi J; Jang BN; Park BJ; Joung YK; Han DK
Langmuir; 2014 Aug; 30(33):10098-106. PubMed ID: 25090045
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of rapamycin-loaded PLGA coating stent.
Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
J Mater Sci Mater Med; 2007 Nov; 18(11):2193-8. PubMed ID: 17607513
[TBL] [Abstract][Full Text] [Related]
6. Controllable biodegradability, drug release behavior and hemocompatibility of PTX-eluting magnesium stents.
Lu P; Fan H; Liu Y; Cao L; Wu X; Xu X
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):23-8. PubMed ID: 21087842
[TBL] [Abstract][Full Text] [Related]
7. Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.
Pan CJ; Tang JJ; Shao ZY; Wang J; Huang N
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):105-11. PubMed ID: 17540543
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo changes to PLGA/sirolimus coating on drug eluting stents.
Xi T; Gao R; Xu B; Chen L; Luo T; Liu J; Wei Y; Zhong S
Biomaterials; 2010 Jul; 31(19):5151-8. PubMed ID: 20382420
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo performance of a dual drug-eluting stent (DDES).
Huang Y; Venkatraman SS; Boey FY; Lahti EM; Umashankar PR; Mohanty M; Arumugam S; Khanolkar L; Vaishnav S
Biomaterials; 2010 May; 31(15):4382-91. PubMed ID: 20189244
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting coating of ginsenoside Rg1 and Re incorporated poly(lactic-co-glycolic acid) on stainless steel 316L: Physicochemical and drug release analyses.
Miswan Z; Lukman SK; Abd Majid FA; Loke MF; Saidin S; Hermawan H
Int J Pharm; 2016 Dec; 515(1-2):460-466. PubMed ID: 27793709
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents.
Pan ChJ; Tang JJ; Weng YJ; Wang J; Huang N
J Control Release; 2006 Nov; 116(1):42-9. PubMed ID: 17046093
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
Wessely R; Hausleiter J; Michaelis C; Jaschke B; Vogeser M; Milz S; Behnisch B; Schratzenstaller T; Renke-Gluszko M; Stöver M; Wintermantel E; Kastrati A; Schömig A
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):748-53. PubMed ID: 15681298
[TBL] [Abstract][Full Text] [Related]
14. A theoretical model to characterize the drug release behavior of drug-eluting stents with durable polymer matrix coating.
Zhao HQ; Jayasinghe D; Hossainy S; Schwartz LB
J Biomed Mater Res A; 2012 Jan; 100(1):120-4. PubMed ID: 21997889
[TBL] [Abstract][Full Text] [Related]
15. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
[TBL] [Abstract][Full Text] [Related]
16. A polymer-free Paclitaxel eluting coronary stent: effects of solvents, drug concentrations and coating methods.
Lamichhane S; Gallo A; Mani G
Ann Biomed Eng; 2014 Jun; 42(6):1170-84. PubMed ID: 24705673
[TBL] [Abstract][Full Text] [Related]
17. Controlled release of sirolimus from a multilayered PLGA stent matrix.
Wang X; Venkatraman SS; Boey FY; Loo JS; Tan LP
Biomaterials; 2006 Nov; 27(32):5588-95. PubMed ID: 16879865
[TBL] [Abstract][Full Text] [Related]
18. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
[TBL] [Abstract][Full Text] [Related]
19. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
[TBL] [Abstract][Full Text] [Related]
20. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
